Lecture 3.6 Lipid Synthesis
Part 1 - Synthesis of triacylglycerol, glycerophospholipids, and sphingolipids
Triacylglycerol and glycerophospholipids are both esters of glycerol
both contain a glycerol backbone
triacylglycerol contains three fatty acid chains
glycerophospholipid contains two fatty acid chains and a polar head group
They share the same precursors : L-glycerol 3-phosphate and fatty acyl-CoA
Fatty acids synthesized/ingested typically have 2 fates:
Incorporation into triacylglycerol (storage of metabolic energy)
Incorporation into phospholipids (components of membranes)
Pathway for L-glycerol 3-phosphate synthesis:
Major: Reduction of dihydroxyacetone phosphate (a glycolytic intermediate) by glycerol 3-phosphate dehydrogenase
Minor (liver and kidney): phosphorylation of glycerol (as a product of lipolysis) by glycerol kinase.
Synthesis of Phosphatidic Acid - common intermediate
The common first reaction in biosynthesis of triacylglycerol and glycerophospholipids.
fatty acyl-CoA is fomred from fatty acid and CoA, catalyzed by acyl-CoA synthetase (same reaction used in fatty acid oxidation)
The 2 free hydroxyl groups of glycerol 3-phosphate are acylated by two molecules of fatty acyl-CoA, catalyzed by acyl transferases
C1 position is usually acylated with a saturated fatty acid while C2 is usually acylated with unsaturated fatty acid.
Phosphatidic acid → triacylglycerol
Triacylglycerol is synthesized from phosphatidic acid and a third fatty acyl-CoA, catalyzed by the tricylglycerol synthetase complex.
3-phosphate is removed from phosphatidic acid to yields 1,2-diacylglycerol (DAG).
DAG is then acylated with a third fatty acyl-CoA
The smooth ER of the liver is the primary site for triacylglycerol synthesis. Triacylglycerol formed are transported to muscle (for use as a fuel) or to adipose tissue (for storage)
Glycerophospholipid - polar head group
Polar head group is linked to diacylglycerol through a phosphodiester bond, where each. of the two hydroxyl groups (1 on the polar head group and 1 on C3 of diacylglycerol) form an ester bond with a common phosphoric acid group.
2 strategies to attach polar head group:
diacylglycerol (DAG) is activated with CDP
Head group is activated with CDP
Strategy 1 breakdown - Synthesis of glycerophsopholipids from CDP-diacylglycerol
Phosphatidic acid first reacts with CTP to form CDP-diacylglycerol. In one CDP-diacylglycerol, one phosphate is from phosphatidic acid and the other is from the alpha phosphate of CTP (CMP).
This reaction consumes two ATP equivalents
Displacement of CMP by the hydroxyl of polar head group yields the product.
Strategy 2 - kennedy pathway - polar head group activated
Choline (a polar head group) - is first phosphorylated by choline kinase to form phosphocholine (1 ATP equivalent)
Phosphocholine reacts with CTP to form CDP-choline (2 ATP equivalents)
In CDP-choline one phosphate is from phosphocholine and the other is from the alpha-phosphate of CTP (CMP)
Displacement of CMP by the C3 hydroxyl of diacylglycerol yields phosphatidylcholine.
Ceramide - parent compound of sphingolipids (structurally analgous to diacylglycerol)
the backbone of ceramide (sphingoid) is derived from serine
Sphingophospholipid - sphingomyeline contains phosphocholine or phosphoethanolamine as its polar head group
Sphingoglycolipids - cerebrosides contain a monosaccharide (glucose or galactose) as their polar head groups
globosides contain a di-, tri-, or tetrasacchride as their polar head groups
gangliosides contain a complex oligosaccharide as their polar head groups
Ceramide synthesis
Condensation of serine and palmitoyl-CoA forms beta-ketosphinganine
NADPH-dependent reduction of beta-ketosphinganine forms sphinganine
Attachment of a fatty acid through an amide linkage forms N-acylsphinganine
Desaturation of the palmitic acid chain (introduction of a double bond) forms ceramide
Attachment of different head grops to the hydroxyl group of ceramide (derived from serine side chain) produces a variety of sphingolipids:
Sphingomyelin - using phosphatidylcholine as phosphocholine donor
Sphingoglycolipids - using UDP-Glc or UDP-Gal as the sugar donor
Part 2 - synthesis of cholesterol (all cells can synthesize cholesterol)
Cholesterol - a component of cellular membrane and precursor of steroid hormone, vitamin D and bile acids.
Excessive deposition in arteries has been associated with cardiovascular disease and stroke.
An intricate balance must be maintained between the biosynthesis, utilization, and transport of cholesterol. All carbon atoms of cholesterol are derived from acetate (acetyl-CoA)
Biosynthesis overview - liver is primary site of biosynthesis
Cholesterol (C27) synthesis occurs in 4 major stages:
Three acetyl CoA (C2) combine to form mevalonate (C6)
Mevalonate (C6) is modified to form Isopentenyl pyrophosphate (C5)
Six molecules of ispentenyl pyrophosphatase and its isomer (C5) combine to form squalene (C30)
Squalene (C30) cyclizes and is further modified to form cholesterol (C27)
Stage 1: Formation of mevalonate from acetyl-CoA
Step 1 leads to mevalonate. 3 Acetyl-CoA molecules combine to form HMG-CoA (chemically similar to ketone body biosynthesis)
HMG-CoA is reduced by HMG-CoA reductase to form mevalonate (reaction 1)
Formation of mevalonate by HMG-CoA reductase is the committed step
This rxn requires 2 NADPH molecules
HMG-CoA reductase is regulated by the cellular cholesterol concentration. It is a common target of cholesterol-lowering drugs.
Drugs called statins are competitive inhibitors of HMG-CoA recutase and are used to treat patients with elevated serum cholesterol level.
Stage 2: Conversion of mevalonate to isopentenyl pyrophosphate
Step 2 leads to isopentenyl pyrophosphate (IPP) and its isomeric form dimethyallyl pyrophosphate (DMAPP)
Mevalonate is phosphorylated twice on the newly formed hydroxyl
group to yield 5-pyrophosphomevalonate (reactions 2 and 3).
• An ATP-dependent decarboxylation and phosphate elimination reaction
converts 5-pyrophosphomevalonate to isopentenyl pyrophosphate
(IPP) (reaction 4).
• Isopentenyl pyrophosphate isomerizes to dimethylallyl pyrophosphate.
• Step 2 requires 3 ATP equivalents.
Stage 3: from isopentenyl pyrophosphate to squalene
Step 3 leads to squalene. Four molecules of isopentenyl pyrophosphate (IPP) and two molecules of dimethylallyl pyrophosphate (DMAPP) combine to form squalene.
• IPP and DMAPP join head-to-tail, producing geranyl pyrophosphate.
• Geranyl pyrophosphate joins to another IPP (head to tail) to form farnesyl pyrophosphate.
• Two farnesyl pyrophosphates join head-to-head to form a phosphate-free squalene.
Energy cost from acetyl-CoA to squalene: 13 NADPH and 18 ATP.
• Four IPP and two DMAPP are needed: each requires 2 NADPH and 3 ATP.
• One NADPH is required in forming squalene from IPP and DMAPP.
Stage 4: squalene cyclizes to form cholesterol
Step 4 leads to cholesterol
Squalene is oxidized by O2 to form squalene epoxide (2,3-oxidosqualene) - another NADPH is required.
• In animals, squalene epoxide cyclizes to form lanosterol, which is converted to cholesterol.
• Conversion from lanosterol to cholesterol occurs in a long series of reaction steps that includes oxidation and loss of three carbon atoms.
Fate of cholesterol after synthesis: In vertebrates, cholesterol synthesized in the liver are exported as bile acids, biliary cholesterol, or cholesteryl esters.
Bile acids - are more polar than cholesterols. They have detergent-like property and make dietary lipids more accessible for digestion by lipases.
Cholesteryl esters - are less polar than cholesterols. They are transported as lipoprotein particles through the blood stream to tissues that use cholesterols.
Cholesterol is the precursor of steroid hormones and vitamin D
Part 3: Regulation of cholesterol level in human body
Lipoprotein particles transport cholesterol and lipids. The surface of these particles is made of a protein (called apolipoprotein) and a phospholipid monolayer.
Apolipoproteins serve to solubilize the lipids and to direct the particles to specific cellular targets. Interior contains cholesterol, triacylglycerol, and cholesteryl ester.
Classified according to their densities: the greater proportion of lipids, the less dense the particle.
4 major classes of lipoprotein particles:
Chylomicrons
• Contains mostly triacylglycerol and some cholesterol.
• Originates in the intestine. Carries dietary triacylglycerol from the intestine to other tissues; cholesterol from the
intestine to the liver.
VLDL (very low density)
• Contains triacylglycerol and cholesteryl esters in high concentration.
• Originates in the liver. Carries triacylglycerol from the liver to muscle and adipose tissue.
LDL (low-density)
• Enriched in cholesterol/cholesteryl ester. ApoB-100 is the major apolipoprotein.
• Produced by removal of triacylglycerol from VLDL. Carries cholesterol from the liver to extrahepatic tissues.
HDL (high-density) – “the good cholesterol”
• High in protein concentration but low in cholesterol/cholesteryl ester and other lipids.
• Carries cholesterol from extrahepatic tissues back to the liver – reverse cholesterol transport
Uptake of cholesterol by extrahepatic tissues
LDL particles deliver cholesterol to extrahepatic tissues where cholesterol enters the cell by receptor-mediated endocytosis.
Deficiency in any of these steps could lead to hypercholesterolemia - high level of cholesterol in the blood.
Mutations in the LDL receptor could lead to cardiovascular disease. ‘
Mutations in the LDL receptor gene can lead to a genetic disease called familial hypercholesterolemia. These mutations lead to decreased efficiency in
receptor-mediated LDL endocytosis, causing high level of LDL in the blood stream.
Excess LDL can cause thickening of the walls of arterial with the subsequent loss of elasticity for increased risk of cardiovascular disease.
Regulation of cholesterol synthesis by protein phosphorylation
HMG-CoA reductase catalyzes the committed step in cholesterol biosynthesis and is the main point of regulation in cholesterol biosynthesis.
Phosphorylation of HMG-CoA reductase by AMP- activated protein kinase (AMPK) inhibits the enzyme activity.
• When ATP level drops, AMPK phosphorylates the enzyme, cholesterol synthesis slows.
• Glucagon stimulates protein phosphorylation, disfavoring cholesterol synthesis.
• Insulin stimulates protein dephosphorylation, favoring cholesterol synthesis.
Regulation of cholesterol synthesis by gene expression
Expression of HMG-CoA reductase is controlled in response to cellular cholesterol level.
Expression of HMG-CoA reductase and other cholesterol synthesis-related genes is controlled by sterol regulatory element-binding proteins (SREBPs).
• When cholesterol level is high, SREBP is sequestered in the ER membrane.
• When cholesterol level declines, SREBP migrates to the Golgi where it is proteolytically processed.
• The released protein fragment moves to the nucleus and binds sterol regulatory element (SRE) to turn on transcription of relevant genes.
Learning objectives for Lecture 26 (Lipid synthesis) - make flashcards
Understand these terms
Phosphodiester bond
Kennedy pathway
Lipoprotein particles
Chylomicron
VLDL
LDL
HDL
Reverse cholesterol transport
Receptor-mediated endocytosis
Hypercholesterolemia
Answer these questions
How is triacylglycerol synthesized in humans?
What is the role of phosphatidic acid in the synthesis of triacylglycerol and glycerophospholipid?
What is the major difference between the two strategies used to attach a polar head group in
glycerophospholipid synthesis?
How are sphingolipids synthesized in humans?
How is cholesterol synthesized in humans?
What bioactive molecules are derivatives of cholesterol?
How are lipids and cholesterol transported in humans?
How is cholesterol synthesis regulated?
Develop these skills
Determine the number of ATP equivalents needed in various lipid synthesis pathways
Know these enzymes
HMG-CoA reductase
Recognize these structures
Metabolites
Triacylglycerol (slide 3)
Glycerophospholipid (slide 3)
Phosphatidic acid (slide 5)
1,2-diacylglycerol (slide 6)
CDP-diacylglycerol (slide 9)
Phosphatidylcholine (slide 10)
Sphingophospholipid (slide 11)
Sphingoglycolipid (slide 11)
Ceramide (slide 12)
Sphingomyelin (slide 13)
Cholesterol (slide 15)
HMG-CoA (slide 17)
Mevalonate (slide 17)
Isopentenyl pyrophosphate (IPP) (slide 18)
Squalene (slide 19)
Bile acid (21)
Cholesteryl ester (21)